Discover Screener Plans Log In Sign Up
STE
STERIS plc
Summary
Business
Earnings Call
Valuation
Profitability
Financial Health
Intel
Yearly Return 10Y annualized return is very good at 14.2% per year
Earnings Expectations STE has met or exceeded earnings expectations in the majority of recent quarters (7/10)
Positive Moderate Price-to-Sales Ratio
Positive Healthy Gross Profit Margin
Negative High Price-to-Earnings Ratio
Negative Elevated EV/EBITDA Ratio

Unlock Complete Analysis

Get access to all key takeaways, detailed financial metrics, and comprehensive stock analysis with our premium subscription.

Complete key takeaways analysis
Advanced financial metrics
Real-time insights & alerts
Start Your Premium Journey

Already have an account? Sign in

Overall, STERIS exhibits a strong business model with solid revenue growth and improved margins. However, legal challenges and declining capital equipment sales present risks. Future prospects appear positive with growth in bioprocessing and a stable healthcare demand, though uncertainties regarding currency and tariffs could impact performance.

Analysis Date: February 6, 2025
Last Updated: May 29, 2025

+278%
+14.2% per year

Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.

Country IE
Exchange NYSE
Industry Medical - Devices
Sector Healthcare
Market Cap $20.14B
CEO Mr. Daniel A. Carestio

STERIS plc is a company that helps keep hospitals and healthcare facilities safe from infections. They provide cleaning products, tools, and equipment that help doctors and nurses perform their jobs effectively. STERIS also offers services to ensure that medical instruments are properly cleaned and sterilized. In addition to healthcare, they provide products for dental offices and support for companies that make medical devices and medicines.

Streams of revenue

Product: 52%
Service: 48%

Geographic Distribution

UNITED STATES: 74%
Other foreign locations: 25%
IRELAND: 2%

Core Products

๐Ÿ”
Endoscopy Products Endoscopic devices
๐Ÿ”ช
Surgical Solutions Surgical equipment
๐Ÿฅ
Healthcare Services Healthcare support
๐Ÿฆ 
Infection Prevention Infection control
๐Ÿงผ
Sterilization Products Medical sterilizers

Business Type

B2B Business to Business

Competitive Advantages

Unlock Competitive Advantages Analysis

Discover all competitive advantages and strategic moats that protect STE's market position.

View Premium Analysis

Key Business Risks

Unlock Complete Risk Analysis

Get comprehensive insight into all key business risks that could impact STE's performance.

Access Full Risk Analysis

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Graham Value Metrics

Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.

๐Ÿ“Š

Unlock Graham value analysis

Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis

โœ“ Intrinsic value calculations
โœ“ Margin of safety analysis
โœ“ Complete Graham criteria checklist
โœ“ Value investing insights
Upgrade to Premium

ROE: 9.463284447418363

ROA: None

Gross Profit Margin: 45.313805347178274

Net Profit Margin: 11.258124576999972

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Scroll horizontally to see more

About Profitability Metrics

Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.

๐Ÿ“Š

Unlock Profitability Metrics

Access detailed profitability metrics with visual gauges and benchmarks

  • โ€ข Return on Equity (ROE) analysis
  • โ€ข Return on Assets (ROA) insights
  • โ€ข Gross & Net Profit Margins
  • โ€ข Industry benchmark comparisons
Sign Up for Premium
๐Ÿ’ช

Unlock profitability strengths

Access detailed analysis of profitability strengths and positive performance indicators

Upgrade to Premium
โš ๏ธ

Unlock profitability weaknesses

Access detailed analysis of profitability weaknesses and areas of concern

Upgrade to Premium

About Financial Health Metrics

Financial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.

๐Ÿฆ

Unlock Financial Health Metrics

Access detailed financial health metrics with visual gauges and risk assessments

  • โ€ข Debt to Equity ratio analysis
  • โ€ข Current ratio & liquidity insights
  • โ€ข Financial risk assessments
  • โ€ข Stability benchmarks
Sign Up for Premium
๐Ÿ›ก๏ธ

Unlock financial strengths

Access detailed analysis of financial health strengths and stability indicators

Upgrade to Premium
โš ๏ธ

Unlock financial weaknesses

Access detailed analysis of financial health weaknesses and risk factors

Upgrade to Premium

Meeting Expectations

7 /10

Higher values indicate better execution and credibility

Recent Results

๐Ÿ”’

Unlock earnings history

View complete earnings history and detailed performance analysis

Upgrade to Premium

EPS

2.60
Estimated
2.74
Actual
+5.38%
Difference

Revenue

$1469026833
Estimated
$1480531000
Actual
+0.78%
Difference
๐Ÿ’ช

Unlock strenghts analysis

Unlock complete business strengths analysis

Upgrade to Premium
โš ๏ธ

Unlock weaknesses analysis

Unlock complete business weaknesses analysis

Upgrade to Premium
๐Ÿš€

Unlock opportunities analysis

Unlock complete future opportunities analysis

Upgrade to Premium
โšก

Unlock risk analysis

Unlock complete future risks analysis

Upgrade to Premium

Insider trading data shows purchase and sale activities by company executives and board members.

Insider Sentiment Analysis

Insider trading patterns can provide insights into how company executives and board members view the stock's future prospects.

๐Ÿ”

Unlock Insider Analysis

Get complete insider sentiment analysis with detailed trading patterns, sentiment indicators, and trend insights

  • โ€ข Insider buy/sell ratio analysis
  • โ€ข Total bought vs sold volumes
  • โ€ข Active insider tracking
  • โ€ข Recent trend analysis
Sign Up for Premium

STE Stock Analysis: STERIS plc Investment Guide

STE (STERIS plc) is a Healthcare company listed on New York Stock Exchange. The stock has generated 14.2% annual returns with an overall investment score of None/100.

Overall, STERIS exhibits a strong business model with solid revenue growth and improved margins. However, legal challenges and declining capital equipment sales present risks. Future prospects appear positive with growth in bioprocessing and a stable healthcare demand, though uncertainties regarding currency and tariffs could impact performance.

STE Key Financial Metrics

STE financial analysis includes comprehensive valuation ratios, profitability metrics, and financial health indicators. The company has a valuation score of 0.24290023659581383/100 and profitability score of 5.0/100 with financial health rated 8.05/100.

About STERIS plc

STERIS plc is a company that helps keep hospitals and healthcare facilities safe from infections. They provide cleaning products, tools, and equipment that help doctors and nurses perform their jobs effectively. STERIS also offers services to ensure that medical instruments are properly cleaned and sterilized. In addition to healthcare, they provide products for dental offices and support for companies that make medical devices and medicines.

STE Investment Recommendation

Based on our comprehensive analysis of STE, investors should consider the company's strong performance track record, earnings consistency (7/10 quarters beat expectations), and current valuation metrics when making investment decisions.

Healthcare Sector Analysis

STE operates in the Medical - Devices industry within the Healthcare sector. This analysis compares STERIS plc performance against industry and sector benchmarks to provide context for investment decisions.

Frequently Asked Questions about STE Stock

Is STE a good investment?

STE (STERIS plc) has generated 14.2% annual returns with an overall score of None/100. Overall, STERIS exhibits a strong business model with solid revenue growth and improved margins. However, legal challenges and declining capital equipment sales present risks. Future prospects appear positive with growth โ€ฆ Investors should consider their risk tolerance and investment goals when evaluating STE.

What is STE P/E ratio and valuation?

STE valuation metrics including P/E ratio, price-to-book ratio, and price-to-sales ratio are analyzed on this page with comparisons to Medical - Devices industry and Healthcare sector benchmarks. The company currently has a valuation score of 0.24290023659581383/100.

Should I buy STE stock now?

The decision to buy STE stock should be based on comprehensive analysis of financial metrics, market conditions, and individual investment goals. Our analysis provides profitability score of 5.0/100, financial health score of 8.05/100, and detailed performance metrics to help inform your investment decision.

What are STE financial health indicators?

STE financial health analysis includes liquidity ratios, debt levels, cash flow metrics, and profitability indicators. The company has a financial health score of 8.05/100 based on comprehensive analysis of balance sheet strength and operational efficiency.

How does STE compare to competitors?

STE performance is benchmarked against Medical - Devices industry peers and Healthcare sector averages. Our analysis includes comparative valuation ratios, profitability metrics, and growth indicators to provide context for STERIS plc's market position.

What are STE historical returns?

STE has generated 14.2% annual returns over the 10Y. Historical performance analysis includes price appreciation, dividend yields, and total shareholder returns compared to market benchmarks.

STE Key Investment Metrics Summary

  • Annual Return: 14.2%
  • Valuation Score: 0.24290023659581383/100
  • Profitability Score: 5.0/100
  • Financial Health Score: 8.05/100
  • Growth Score: 3.0448106185896298/100
  • Earnings Beat Rate: 7/10 quarters
  • Sector: Healthcare
  • Industry: Medical - Devices
  • Exchange: New York Stock Exchange
  • Market Cap: 20137276273

STE Investment Thesis

STERIS plc (STE) represents a strong investment opportunity in the Healthcare sector. With an overall score of None/100, the company demonstrates areas for financial improvement.

Investment Strengths

  • Moderate Price-to-Sales Ratio
  • Healthy Gross Profit Margin
  • Strong Operating Profit Margin
  • Low Debt Levels
  • Strong Interest Coverage
  • Solid Current and Quick Ratios
  • Strong Revenue Growth
  • Improved Margins
  • Strong Backlog and Order Growth
  • Cautiously Optimistic Growth in Bioprocessing
  • Stable Healthcare Demand
  • Tightened Revenue Guidance

Investment Risks

  • High Price-to-Earnings Ratio
  • Elevated EV/EBITDA Ratio
  • Moderate Net Profit Margin
  • Low Cash Ratio
  • Legal and Regulatory Challenges
  • Capital Equipment Revenue Decline
  • Uncertainties due to Currency Fluctuations
  • Potential Impact of Tariffs
Home Screener Search Profile

During the beta period, we're currently displaying stocks from the S&P 500 index only. More stocks will be added soon.

Loading...